Profile
Daniel F.
Hoth is currently the President of Eric Hoth Consulting LLC since 2001.
He was also the Director-AIDS Division at National Institute of Allergy & Infectious Diseases from 1981 to 1993 and the Chief Medical Officer at Cell Genesys, Inc. from 1993 to 1997, Axys Pharmaceuticals, Inc. from 1999 to 2001, and Aduro BioTech, Inc. He was also the Acting Chief Medical Officer at Semafore Pharmaceuticals, Inc. and the Chief-Investigational Drug Branch at National Cancer Institute.
He received his undergraduate degree from Franklin & Marshall College and his doctorate from Georgetown University.
Daniel F. Hoth active positions
| Companies | Position | Start |
|---|---|---|
Eric Hoth Consulting LLC | President | 30/11/2001 |
Former positions of Daniel F. Hoth
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 21/04/2019 |
| STATERA BIOPHARMA, INC. | Director/Board Member | 13/04/2015 |
| SEAGEN INC. | Director/Board Member | 30/09/2010 |
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | 23/03/2010 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Corporate Officer/Principal | 30/11/2001 |
Training of Daniel F. Hoth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and discovers drugs for multiple disorders including cancer | Retail Trade |
Acologix, Inc.
Acologix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical drugs | Health Technology |
Eric Hoth Consulting LLC | |
National Institute of Allergy & Infectious Diseases
National Institute of Allergy & Infectious Diseases General GovernmentGovernment Operates as an agency of the United States department of health and human services | Government |
- Stock Market
- Insiders
- Daniel F. Hoth
















